Key result
Personalized post-PCI medical therapy improves clinical outcomes by balancing thrombotic and bleeding risks.
Why the study?
Cardiovascular medicine is shifting toward personalized therapy, prompting an exploration of the significance, challenges, and future directions of individualized treatment strategies after coronary stent implantation.
Personalized medicinal therapy post stent implantation, considering genetics, clinical factors, and patient preferences, holds immense promise for optimizing treatment outcomes and balancing ischemic and bleeding risks.
Should not yet change practice; leaves open validation of guided personalization in prospective RCTs.
The field of cardiovascular medicine is undergoing a transformative shift towards personalized medicinal therapy, particularly in the context of post stent implantation. This narrative review explores the significance, challenges, and future directions of individualized treatment strategies for patients with coronary stents. The review highlights the pivotal role of personalized approaches in optimizing treatment efficacy and minimizing adverse events. Real-world clinical studies and trials underscore the importance of tailoring antiplatelet therapy based on platelet function testing, genetic testing, and risk scoring. These studies reveal that personalized medicinal treatment improves clinical outcomes by balancing preventing thrombotic events and mitigating bleeding risks. Challenges, including cost, test availability, patient adherence, and ethical considerations, are discussed in depth, shedding light on the complexities of implementing personalized approaches. Technological advancements, including omics data integration, artificial intelligence, and big data analytics, shape the future of personalized medicinal therapy. These tools enable precise pharmacogenomic selection of medications and the development of integrated risk-scoring systems. Patient engagement and education are also central, with empowered patients and remote monitoring contributing to collaborative decision-making. In conclusion, the narrative review underscores that personalized medicinal therapy post stent implantation holds immense promise for revolutionizing cardiovascular care. By embracing a comprehensive approach that considers genetics, clinical factors, and patient preferences, healthcare providers can optimize treatment outcomes and improve patient quality of life. The evolving landscape of personalized medicine offers a glimpse into a future where tailored treatment strategies become the cornerstone of precision cardiovascular care.
No takes yet. Share an insight, caveat, or question.
Mohamad et al. (2023) conducted a review in Coronary artery disease post stent implantation. Personalized medicinal therapy was evaluated. Personalized medicinal therapy post stent implantation, guided by platelet function testing, genetic testing, and risk scoring, improves clinical outcomes by balancing thrombotic and bleeding risks.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: